BioBreakthroughs

#38 – Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals

May 8, 2024

#37 – Colin Weller, VP & GM Evidence Platform at Medable

April 17, 2024

#36 – Stella K. Vnook, CEO at Likarda

March 20, 2024

#35 – Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio

March 13, 2024

#34 – Cary Claiborne, CEO of Adial Pharmaceuticals

February 14, 2024

#33 – Marcio Souza, CEO Of Praxis Precision Medicines

February 5, 2024

#32 – Steve Reed, Co-Founder & Chief Executive Officer of HDT Bio

January 31, 2024

#31 – Gadi Saarony, CEO of Advarra

January 18, 2024

#30 – David Stein, CEO of Babson Diagnostics

January 12, 2024

#29 – Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University

January 8, 2024